Skip to main content
Report this ad

See also:

Propanc seeks patent protection on new cancer treatment

Propanc Health Group Corp. (OTC: PPCH) announced steps toward potentially receiving patent protection in the United States and Europe with its proprietary technology designed to treat certain forms of cancer.
Propanc Health Group Corp. (OTC: PPCH) announced steps toward potentially receiving patent protection in the United States and Europe with its proprietary technology designed to treat certain forms of cancer.
Photo by Spencer Platt/Getty Images
Report this ad